小细胞肺癌：“黑匣子”终于要打开了吗？
Small-Cell Lung Cancer: Is the Black Box Finally Opening Up?
作者信息
Hiddinga Birgitta I, Kok Klaas
机构信息
Department of Pulmonary Medicine and Tuberculosis, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.
Department of Genetics, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, The Netherlands.
出版信息
Cancers (Basel). 2021 Jan 11;13(2):236. doi: 10.3390/cancers13020236.
Abstract
Small-cell lung cancer (SCLC) is an aggressive cancer that originates from the neuroendocrine crest [...].
摘要
小细胞肺癌（SCLC）是一种起源于神经内分泌嵴的侵袭性癌症[……]
相似文献
1
Small-Cell Lung Cancer: Is the Black Box Finally Opening Up?小细胞肺癌：“黑匣子”终于要打开了吗？
Cancers (Basel). 2021 Jan 11;13(2):236. doi: 10.3390/cancers13020236.
2
3
A clinicopathological study of peripheral, small-sized high-grade neuroendocrine tumours of the lung: differences between small-cell lung carcinoma and large-cell neuroendocrine carcinoma.肺外周、小细胞型高级神经内分泌肿瘤的临床病理研究：小细胞肺癌与大细胞神经内分泌癌的区别。
Eur J Cardiothorac Surg. 2012 Apr;41(4):841-6. doi: 10.1093/ejcts/ezr132. Epub 2011 Dec 21.
4
Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets.肺大细胞神经内分泌癌的下一代测序揭示了小细胞癌样和非小细胞癌样亚组。
Clin Cancer Res. 2016 Jul 15;22(14):3618-29. doi: 10.1158/1078-0432.CCR-15-2946. Epub 2016 Mar 9.
5
Comparative study of large cell neuroendocrine carcinoma and small cell lung carcinoma in high-grade neuroendocrine tumors of the lung: a large population-based study.肺高级别神经内分泌肿瘤中，大细胞神经内分泌癌与小细胞肺癌的比较研究：一项基于大人群的研究
J Cancer. 2019 Jul 10;10(18):4226-4236. doi: 10.7150/jca.33367. eCollection 2019.
6
Clinicopathological characteristics of thyroid transcription factor 1-negative small cell lung cancers.甲状腺转录因子 1 阴性小细胞肺癌的临床病理特征。
Hum Pathol. 2018 Sep;79:127-134. doi: 10.1016/j.humpath.2018.05.009. Epub 2018 May 19.
7
Small cell lung cancer, an epithelial to mesenchymal transition (EMT)-like cancer: significance of inactive Notch signaling and expression of achaete-scute complex homologue 1.小细胞肺癌，一种类似上皮-间质转化（EMT）的癌症：无活性Notch信号传导的意义及achaete-scute复合体同源物1的表达
Hum Cell. 2017 Jan;30(1):1-10. doi: 10.1007/s13577-016-0149-3. Epub 2016 Oct 26.
8
Sonic hedgehog signaling pathway promotes INSM1 transcription factor in neuroendocrine lung cancer. Sonic hedgehog 信号通路促进神经内分泌肺癌中的 INSM1 转录因子。
Cell Signal. 2018 Jun;46:83-91. doi: 10.1016/j.cellsig.2018.02.014. Epub 2018 Mar 1.
9
Neuroendocrine-specific protein (NSP)-reticulons as independent markers for non-small cell lung cancer with neuroendocrine differentiation. An in vitro histochemical study.神经内分泌特异性蛋白（NSP）-网质蛋白作为具有神经内分泌分化的非小细胞肺癌的独立标志物。一项体外组织化学研究。
Histochem Cell Biol. 1997 Aug;108(2):155-65. doi: 10.1007/s004180050157.
10
High grade neuroendocrine lung tumors: pathological characteristics, surgical management and prognostic implications.高级别神经内分泌肺肿瘤：病理特征、手术处理及预后意义。
Lung Cancer. 2013 Sep;81(3):404-409. doi: 10.1016/j.lungcan.2013.05.008. Epub 2013 Jun 14.
引用本文的文献
1
Real-world data of immune-related adverse events in lung cancer patients receiving immune-checkpoint inhibitors.接受免疫检查点抑制剂治疗的肺癌患者免疫相关不良事件的真实世界数据。
Immunotherapy. 2025 Apr;17(5):321-329. doi: 10.1080/1750743X.2025.2488728. Epub 2025 Apr 4.
本文引用的文献
1
SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization.SCLC 亚型的定义：ASCL1、NEUROD1、POU2F3 和 YAP1：全面的免疫组化和组织病理学特征。
J Thorac Oncol. 2020 Dec;15(12):1823-1835. doi: 10.1016/j.jtho.2020.09.009. Epub 2020 Oct 1.
2
Targeting focal adhesion kinase in cancer cells and the tumor microenvironment.靶向肿瘤细胞和肿瘤微环境中的黏着斑激酶。
Exp Mol Med. 2020 Jun;52(6):877-886. doi: 10.1038/s12276-020-0447-4. Epub 2020 Jun 9.
3
Role of Focal Adhesion Kinase in Small-Cell Lung Cancer and Its Potential as a Therapeutic Target.粘着斑激酶在小细胞肺癌中的作用及其作为治疗靶点的潜力。
Cancers (Basel). 2019 Oct 29;11(11):1683. doi: 10.3390/cancers11111683.
4
Increased Expression and Activation of FAK in Small-Cell Lung Cancer Compared to Non-Small-Cell Lung Cancer.与非小细胞肺癌相比，小细胞肺癌中粘着斑激酶的表达和激活增加。
Cancers (Basel). 2019 Oct 10;11(10):1526. doi: 10.3390/cancers11101526.
5
Technological and Therapeutic Advances in Advanced Small Cell Lung Cancer.晚期小细胞肺癌的技术与治疗进展
Cancers (Basel). 2019 Oct 15;11(10):1570. doi: 10.3390/cancers11101570.
6
MET Inhibitors in Small Cell Lung Cancer: From the Bench to the Bedside.小细胞肺癌中的MET抑制剂：从实验室到临床
Cancers (Basel). 2019 Sep 20;11(10):1404. doi: 10.3390/cancers11101404.
7
Tumor-Targeted Drug Conjugates as an Emerging Novel Therapeutic Approach in Small Cell Lung Cancer (SCLC).肿瘤靶向药物偶联物作为小细胞肺癌（SCLC）中一种新兴的新型治疗方法。
Cancers (Basel). 2019 Sep 3;11(9):1297. doi: 10.3390/cancers11091297.
8
Targeting DNA Replication Stress and DNA Double-Strand Break Repair for Optimizing SCLC Treatment.靶向DNA复制应激和DNA双链断裂修复以优化小细胞肺癌治疗
Cancers (Basel). 2019 Sep 2;11(9):1289. doi: 10.3390/cancers11091289.
9
Author Correction: Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data.作者更正：小细胞肺癌的分子亚型：人类和小鼠模型数据的综合分析
Nat Rev Cancer. 2019 Jul;19(7):415. doi: 10.1038/s41568-019-0164-2.
10
Future Options of Molecular-Targeted Therapy in Small Cell Lung Cancer.小细胞肺癌分子靶向治疗的未来选择
Cancers (Basel). 2019 May 17;11(5):690. doi: 10.3390/cancers11050690.
Zotero 插件